Lateral Plantar Artery Embolization For Plantar Fasciitis

Part of paid clinical trials in Libertyville, Illinois.

Sponsor
Joint & Vascular Institute
Study ID
NCT07395128
Phase
PHASE1
Status
Recruiting

Conditions

  • Plantar Fasciitis
  • Plantar Fasciitis, Chronic

Eligibility Criteria

Sex
ALL
Age
25 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Lipiodol — DEVICE
    Participants will receive a transcatheter arterial embolization of the lateral plantar artery branches. The intervention involves the selective catheterization of the calcaneal branches under fluoroscopic guidance using a microcatheter. A mixture of Lipiodol (a transient liquid embolic agent) and iodinated contrast media is injected until an endpoint of "near stasis" is reached. A maximum of 5 mL of Lipiodol will be used per procedure. This intervention specifically targets the hypervascularity (neovascularization) associated with chronic plantar fasciitis to alleviate pain and reduce inflammation.

Study Details

The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are: Does this procedure successfully reduce chronic heel pain as measured by the Visual Analog Scale (VAS) over 12 months? How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device? Participants will: Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels in the foot. Receive a phone call one day after the procedure to check for early side effects. Participate in four follow-up telehealth visits over the course of one year (at 1, 3, 6, and 12 months). Complete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.

Key Dates

Start date
Dec 20, 2025
Status verified
Feb 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Lateral Plantar Artery Embolization

Primary Outcome Measure

Pain Change [ Time Frame: Baseline to 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Joint and Vascular InstituteLibertyvilleIllinois60048
Layth Alkhani
847-584-3959

Find similar trials in Libertyville, IL

Related Studies